NR3C1 and arthritic joint disease: Yet, by using cell type-specific GR-deficient mice it could be demonstrated that exogenous GC treatment of inflammation in antigen-induced arthritis was effective when murine T cells, but not myeloid or B cells, expressed the GR [22].